BRCA1 and cancer: In addition to cancer-type-specific thresholds that reduce the number of unexplained cases, we demonstrated the importance of including the promoter methylation status of BRCA1 and RAD51C in order to evaluate the fraction of HRD cases that are explained by known causes.